{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:06:28Z","timestamp":1791950788264,"version":"4.3.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004024","name":"Jinan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Immunology and Immunopathology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.vetimm.2025.111045","type":"journal-article","created":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T06:32:36Z","timestamp":1765089156000},"page":"111045","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["G-CSF in feline medicine: From molecular mechanisms to clinical applications"],"prefix":"10.1016","volume":"291","author":[{"given":"Lei","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaozhen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1236-369X","authenticated-orcid":false,"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetimm.2025.111045_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0165-2427(00)00232-4","article-title":"The use of human hematopoietic growth factors (rhGM-CSF and rhEPO) as a supportive therapy for FIV-infected cats","volume":"77","author":"Arai","year":"2000","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2025.111045_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.vetmic.2019.03.015","article-title":"Use of recombinant canine granulocyte-colony stimulating factor to increase leukocyte count in dogs naturally infected by canine parvovirus","volume":"231","author":"Armenise","year":"2019","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.vetimm.2025.111045_bib3","first-page":"993","article-title":"Stimulation of human and murine bone marrow cell colony formation by colony-stimulating factors obtained from the urine of mice bearing leukocytosis-inducing fibrosarcoma","volume":"75","author":"Bessho","year":"1984","journal-title":"Gan"},{"key":"10.1016\/j.vetimm.2025.111045_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25094807","article-title":"Balancing benefits and risks: a literature review on hypersensitivity reactions to human G-CSF (Granulocyte Colony-Stimulating Factor)","volume":"25","author":"Bumbacea","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.vetimm.2025.111045_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetimm.2021.110322","article-title":"APB-F1, a long-acting feline granulocyte colony-stimulating factor fusion protein, created by exploiting FL335, a chimeric Fab specific for feline serum albumin","volume":"240","author":"Chi","year":"2021","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2025.111045_bib6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tvjl.2014.01.019","article-title":"Pegylated feline granulocyte colony-stimulating factor increases neutrophil levels in cats","volume":"200","author":"Coleman","year":"2014","journal-title":"Vet. J."},{"key":"10.1016\/j.vetimm.2025.111045_bib7","first-page":"1229","article-title":"Neutrophil function in normal and Chediak-Higashi syndrome cats following administration of recombinant canine granulocyte colony-stimulating factor","volume":"20","author":"Colgan","year":"1992","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.vetimm.2025.111045_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ani14243582","article-title":"Filgrastim efficiency in cats naturally infected with feline panleukopenia virus","volume":"14","author":"Dascalu","year":"2024","journal-title":"Animals"},{"key":"10.1016\/j.vetimm.2025.111045_bib9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2885.2009.01153.x","article-title":"Hematologic improvement in dogs with parvovirus infection treated with recombinant canine granulocyte-colony stimulating factor","volume":"33","author":"Duffy","year":"2010","journal-title":"J. Vet. Pharm. Ther."},{"key":"10.1016\/j.vetimm.2025.111045_bib10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/cyto.2001.0910","article-title":"Isolation, nucleotide sequence and expression of a cdna encoding feline granulocyte colony-stimulating factor","volume":"14","author":"Dunham","year":"2001","journal-title":"Cytokine"},{"key":"10.1016\/j.vetimm.2025.111045_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tvjl.2006.08.001","article-title":"Granulocyte and granulocyte macrophage colony-stimulating factors as therapy in human and veterinary medicine","volume":"174","author":"Fern\u00e1ndez-Var\u00f3n","year":"2007","journal-title":"Vet. J."},{"key":"10.1016\/j.vetimm.2025.111045_bib12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.molimm.2006.02.009","article-title":"GCSF receptor regulates antigen uptake and expression of cytokines and costimulatory molecules in dendritic cells","volume":"44","author":"Geng","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.vetimm.2025.111045_bib13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nri2356","article-title":"Colony-stimulating factors in inflammation and autoimmunity","volume":"8","author":"Hamilton","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.vetimm.2025.111045_bib14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/1098612X20926893","article-title":"LOPH: a novel chemotherapeutic protocol for feline high-grade multicentric or mediastinal lymphoma, developed in an area endemic for feline leukemia virus","volume":"23","author":"Horta","year":"2021","journal-title":"J. Feline Med Surg."},{"key":"10.1016\/j.vetimm.2025.111045_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050391","article-title":"Granulocyte colony-stimulating factor (G-CSF) protects oligodendrocyte and promotes hindlimb functional recovery after spinal cord injury in rats","volume":"7","author":"Kadota","year":"2012","journal-title":"Plos One"},{"key":"10.1016\/j.vetimm.2025.111045_bib16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/vms3.706","article-title":"Transient thrombocytopenia in a cat following G-CSF treatment","volume":"8","author":"Kim","year":"2022","journal-title":"Vet. Med Sci."},{"key":"10.1016\/j.vetimm.2025.111045_bib17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.vetimm.2006.02.004","article-title":"Natural feline coronavirus infection: differences in cytokine patterns in association with the outcome of infection","volume":"112","author":"Kipar","year":"2006","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2025.111045_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5326\/JAAHA-MS-7409","article-title":"Filgrastim Use in the Treatment of Azathioprine-Induced Myelosuppression Toxicity After Prescription Error in the Feline","volume":"60","author":"Klar","year":"2024","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"10.1016\/j.vetimm.2025.111045_bib19","doi-asserted-by":"crossref","first-page":"968","DOI":"10.2174\/092986708784049649","article-title":"Granulocyte colony-stimulating factor (G-CSF) for cardio- and cerebrovascular regenerative applications","volume":"15","author":"Klocke","year":"2008","journal-title":"Curr. Med Chem."},{"key":"10.1016\/j.vetimm.2025.111045_bib20","first-page":"609","article-title":"Treatment of severe neutropenias in dogs and cats with filgrastim","volume":"23","author":"Kraft","year":"1995","journal-title":"Tierarzt Prax."},{"key":"10.1016\/j.vetimm.2025.111045_bib21","doi-asserted-by":"crossref","first-page":"11398","DOI":"10.1073\/pnas.0404328101","article-title":"Critical role for granulocyte colony-stimulating factor in inflammatory arthritis","volume":"101","author":"Lawlor","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.vetimm.2025.111045_bib22","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.2741\/2041","article-title":"The interaction of G-CSF with its receptor","volume":"11","author":"Layton","year":"2006","journal-title":"Front Biosci."},{"key":"10.1016\/j.vetimm.2025.111045_bib23","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1006\/jmbi.1993.1617","article-title":"Crystal structure of canine and bovine granulocyte-colony stimulating factor (G-CSF)","volume":"234","author":"Lovejoy","year":"1993","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.vetimm.2025.111045_bib24","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/S0301-472X(99)00092-2","article-title":"Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34+ cells that rapidly engraft lethally x-irradiated nonhuman primates","volume":"27","author":"Macvittie","year":"1999","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.vetimm.2025.111045_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens9110893","article-title":"Colony stimulating factors in early feline infectious peritonitis virus infection of monocytes and in end stage feline infectious peritonitis; a combined in vivo and in vitro approach","volume":"9","author":"Malbon","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.vetimm.2025.111045_bib26","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/leu.2013.321","article-title":"Alternatively spliced, truncated GCSF receptor promotes leukemogenic properties and sensitivity to JAK inhibition","volume":"28","author":"Mehta","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.vetimm.2025.111045_bib27","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.2460\/javma.1992.200.12.1957","article-title":"Effects of recombinant canine granulocyte colony-stimulating factor on white blood cell production in clinically normal and neutropenic dogs","volume":"200","author":"Mishu","year":"1992","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"10.1016\/j.vetimm.2025.111045_bib28","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0195-5616(95)50163-9","article-title":"Hematopoietic growth factors: frontiers for cure","volume":"25","author":"Ogilvie","year":"1995","journal-title":"Vet. Clin. North Am. Small Anim. Pract."},{"key":"10.1016\/j.vetimm.2025.111045_bib29","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ 372"},{"key":"10.1016\/j.vetimm.2025.111045_bib30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.vetimm.2005.06.010","article-title":"FIV-infected cats respond to short-term rHuG-CSF treatment which results in anti-G-CSF neutralizing antibody production that inactivates drug activity","volume":"108","author":"Phillips","year":"2005","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2025.111045_bib31","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/vco.12198","article-title":"Febrile neutropenia in cats treated with chemotherapy","volume":"15","author":"Pierro","year":"2017","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.vetimm.2025.111045_bib32","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.bmt.1700899","article-title":"Inhibition of lymphocyte blastogenic response in healthy donors treated with recombinant human granulocyte colony-stimulating factor (rhG-CSF): possible role of lactoferrin and interleukin-1 receptor antagonist","volume":"20","author":"Rutella","year":"1997","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.vetimm.2025.111045_bib33","doi-asserted-by":"crossref","first-page":"7085","DOI":"10.4049\/jimmunol.175.11.7085","article-title":"Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance","volume":"175","author":"Rutella","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.vetimm.2025.111045_bib34","doi-asserted-by":"crossref","unstructured":"Souza L.M., Boone T.C., Gabrilove J., Lai P.H., Zsebo K.M., Murdock D.C., Chazin V.R., Bruszewski J., Lu H., Chen K.K., Barendt J., Platzer E., Moore M., Mertelsmann R., and Welte K. 1986. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells.","DOI":"10.1126\/science.232.4746.61"},{"key":"10.1016\/j.vetimm.2025.111045_bib35","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1111\/1759-7714.14544","article-title":"PEG-rhG-CSF for prophylaxis of neutropenia after chemotherapy in patients with non-small cell lung cancer: A multicenter, prospective, randomized study","volume":"13","author":"Sun","year":"2022","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.vetimm.2025.111045_bib36","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2741\/2103","article-title":"Granulocyte colony-stimulating factor and its receptor in normal myeloid cell development, leukemia and related blood cell disorders","volume":"12","author":"Touw","year":"2007","journal-title":"Front Biosci."},{"key":"10.1016\/j.vetimm.2025.111045_bib37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.tcam.2009.02.004","article-title":"Supporting the veterinary cancer patient on chemotherapy: neutropenia and gastrointestinal toxicity","volume":"24","author":"Vail","year":"2009","journal-title":"Top. Companion Anim. Med"},{"key":"10.1016\/j.vetimm.2025.111045_bib38","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1182\/blood.V93.2.425","article-title":"Granulocyte colony-stimulating factor to prevent the progression of systemic nonresponsiveness in systemic inflammatory response syndrome and sepsis","volume":"93","author":"Weiss","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.vetimm.2025.111045_bib39","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1582-4934.2007.00101.x","article-title":"Cell biology and clinical promise of G-CSF: immunomodulation and neuroprotection","volume":"11","author":"Xiao","year":"2007","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.vetimm.2025.111045_bib40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-2427(02)00259-3","article-title":"Expression in Escherichia coli and purification of the functional feline granulocyte colony-stimulating factor","volume":"90","author":"Yamamoto","year":"2002","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2025.111045_bib41","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0378-1119(01)00575-3","article-title":"Molecular cloning and expression of the cDNA encoding feline granulocyte colony-stimulating factor","volume":"274","author":"Yamamoto","year":"2001","journal-title":"Gene"},{"key":"10.1016\/j.vetimm.2025.111045_bib42","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0165-2427(98)00165-2","article-title":"Feline bone marrow transplantation: its use in FIV-infected cats","volume":"65","author":"Yamamoto","year":"1998","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2025.111045_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2024.110282","article-title":"Recombinant feline herpesvirus-1 (FHV-1) expressing granulocyte colony-stimulating factor (G-CSF) exhibits enhanced protective efficacy in felines","volume":"601","author":"Yang","year":"2025","journal-title":"Virology"},{"key":"10.1016\/j.vetimm.2025.111045_bib44","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/cbin.11398","article-title":"G-CSF-dependent neutrophil differentiation requires downregulation of MAPK activities through the Gab2 signaling pathway","volume":"44","author":"Zhao","year":"2020","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.vetimm.2025.111045_bib45","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.4155\/bio-2018-0071","article-title":"Immunogenicity assessment of tbo-filgrastim in cancer patients receiving chemotherapy","volume":"10","author":"Zou","year":"2018","journal-title":"Bioanalysis"}],"container-title":["Veterinary Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242725001655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242725001655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T21:44:42Z","timestamp":1773870282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165242725001655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":45,"alternative-id":["S0165242725001655"],"URL":"https:\/\/doi.org\/10.1016\/j.vetimm.2025.111045","relation":{},"ISSN":["0165-2427"],"issn-type":[{"value":"0165-2427","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"G-CSF in feline medicine: From molecular mechanisms to clinical applications","name":"articletitle","label":"Article Title"},{"value":"Veterinary Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetimm.2025.111045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111045"}}